Amgen, Inc. (Public, NASDAQ:AMGN) decreased -0.75%, currently trading at $56.28 and its overall traded volume was 495,992.00 shares while reporting at 11:00 AM, against its average volume of 7.24M. AMGN opened the day at $56.53, it made an intraday low of $56.01 and an intraday high of $56.67. The stock has a 52 week low of $50.26 and 52 week high of $61.26. AMGN's market capitalization is 53.18B and it has 944.82M outstanding shares.
About Amgen, Inc. (Public, NASDAQ:AMGN)
Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Its principal products include Aranesp (darbepoetin alfa) and EPOGEN (Epoetin alfa), erythropoietic-stimulating agents (ESAs) that stimulate the production of red blood cells; Neulasta (pegfilgrastim), a pegylated protein, based on the Filgrastim molecule, and NEUPOGEN (Filgrastim), a recombinant-methionyl human granulocyte colony-stimulating factor (G-CSF), both of which selectively stimulate the production of neutrophils (a type of white blood cell that helps the body fight infection), and Enbrel (etanercept), an inhibitor of tumor necrosis factor (TNF), a substance that plays a role in the body’s response to inflammatory diseases.
Peregrine Pharmaceuticals (Public, NASDAQ:PPHM) decreased -5.44%, currently trading at $2.22 and its overall traded volume was 490,872.00 shares while reporting at 11:00 AM, against its average volume of 547,405.00. PPHM opened the day at $2.30, it made an intraday low of $2.07 and an intraday high of $2.30. The stock has a 52 week low of $1.25 and 52 week high of $4.30. PPHM's market capitalization is 142.06M and it has 63.93M outstanding shares.
About Peregrine Pharmaceuticals (Public, NASDAQ:PPHM)
Peregrine Pharmaceuticals, Inc. (Peregrine) is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of cancer and viral infections. The Company is advancing its two Phase II oncology platforms, as well as its Phase I hepatitis C virus (HCV) program. The Company’s Phase II trials in lung, breast, and brain cancers have demonstrated results, leading to two randomized Phase II trials in non-small cell lung cancer (NSCLC). Its pipeline of investigational monoclonal antibodies includes bavituximab and cotara. Bavituximab is a phosphatidylserine (PS) targeting monoclonal antibody, which represents an approach to treating cancer and has demonstrated broad-spectrum potential in multiple solid tumors. Its brain cancer therapy, Cotara is a targeted monoclonal antibody linked to a radioisotope that is administered directly into the tumor, destroying the tumor from the inside out, with minimal exposure to healthy tissue.
Activision Blizzard, Inc. (Public, NASDAQ:ATVI) decreased -0.80%, currently trading at $12.35 and its overall traded volume was 486,650.00 shares while reporting at 11:00 AM, against its average volume of 9.22M. ATVI opened the day at $12.44, it made an intraday low of $12.31 and an intraday high of $12.45. The stock has a 52 week low of $9.93 and 52 week high of $12.65. ATVI's market capitalization is 14.89B and it has 1.21B outstanding shares.
About Activision Blizzard, Inc. (Public, NASDAQ:ATVI)
Activision Blizzard, Inc. (Activision Blizzard) is an online, personal computer (PC), console and handheld game publisher. Through Activision Publishing, Inc. (Activision), the Company is an international publisher of interactive software products and peripherals. The Company operates in three operating segments: Activision Publishing, which is engaged in publishing interactive entertainment software and peripherals, which includes Activision Publishing, Inc., and studios, assets, and titles; Blizzard Entertainment, Inc. and its subsidiaries, which is engaged in publishing PC games and online subscription-based games in the massively multiplayer online role-playing game (MMORPG) category (Blizzard), and Activision Blizzard Distribution, which is engaged in distribution of interactive entertainment software and hardware products (Distribution).
Power-One, Inc. (Public, NASDAQ:PWER) decreased -0.84%, currently trading at $10.61 and its overall traded volume was 484,502.00 shares while reporting at 11:00 AM, against its average volume of 4.71M. PWER opened the day at $10.63, it made an intraday low of $10.55 and an intraday high of $10.67. The stock has a 52 week low of $3.02 and 52 week high of $13.04. PWER's market capitalization is 1.13B and it has 106.67M outstanding shares.
About Power-One, Inc. (Public, NASDAQ:PWER)
Power-One, Inc. (Power-One) is a designer and manufacturer of energy-efficient power conversion and power management solutions for renewable/alternative energy, routers, data storage, servers and data centers, wireless communications, optical networking, semiconductor test equipment, industrial markets and custom applications. Its products convert, process and manage electrical energy, in both alternating current (AC) and direct current (DC) form. In the renewable energy market, it sells a range of products of high-efficiency inverters. The Company designs, sells and services its products globally and has resources in Europe, North America and the Asia-Pacific region. It organizes its products into two product lines: embedded products and power systems. Embedded products include AC/DC power supplies, DC/DC converters (including brick converters and POL converters), and smart motor control. Power systems products include DC power systems and Renewable Energy products.
Akamai Technologies, Inc. (Public, NASDAQ:AKAM) decreased -0.73%, currently trading at $47.75 and its overall traded volume was 483,135.00 shares while reporting at 11:00 AM, against its average volume of 4.15M. AKAM opened the day at $47.83, it made an intraday low of $47.28 and an intraday high of $47.92. The stock has a 52 week low of $24.50 and 52 week high of $54.65. AKAM's market capitalization is 8.71B and it has 182.34M outstanding shares.
About Akamai Technologies, Inc. (Public, NASDAQ:AKAM)
Akamai Technologies, Inc. (Akamai) provides services for accelerating and improving the delivery of content and applications over the Internet, ranging from live and on-demand streaming video capabilities to conventional content on Websites, to tools that help people transact business and reach out to new and existing customers. The Company’s solutions are designed to help companies, government agencies and other enterprises. It offers application performance services, services and solutions for digital media and software distribution and storage, content and application delivery, online advertising-related services and other specialized Internet-based offerings. During the year ended December 31, 2009, the Company launched the Akamai HD Network, a new high definition (HD), streaming delivery platform that is designed to enable its customers to offer live and on-demand HD video online to viewers. In June 2010, it acquired Velocitude, a mobile services platform.
